Quantitative optical coherence tomography angiography biomarkers Following a Switch to Brolucizumab in Neovascular age-related macular degeneration
Intravitreal brolucizumab demonstrated favorable anatomical improvements and maintained visual outcomes over 12 months. Quantitative OCTA biomarkers, particularly FD, may serve as imaging indicators of disease activity and treatment response in eyes with nAMD undergoing a therapy switch.
Authors
- Ki‐Young Kim (ORCID: https://orcid.org/0000-0002-0407-3018)
- Seung-Young Yu
- Jaehwan Choi
- Seungyeon Lee
Institutions
- Kyung Hee University Medical Center (KR)
Publication Details
- Journal
- Korean Journal of Ophthalmology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.3341/kjo.2025.0144
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00